ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 27 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,995,000 | +93.9% | 9,030,000 | +67.2% | 0.01% | +60.0% |
| Q1 2019 | $5,155,000 | -61.6% | 5,400,000 | -68.0% | 0.01% | -64.3% |
| Q4 2018 | $13,441,000 | +12.3% | 16,850,000 | +50.6% | 0.01% | +27.3% |
| Q3 2018 | $11,971,000 | +16.6% | 11,189,000 | +13.2% | 0.01% | +10.0% |
| Q2 2018 | $10,264,000 | – | 9,881,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 63,517,000 | $59,031,000 | 5.81% |
| Mohican Financial Management, LLC | 1,250,000 | $1,163,000 | 1.70% |
| Redmile Group, LLC | 25,000,000 | $23,197,000 | 0.66% |
| WOLVERINE ASSET MANAGEMENT LLC | 34,195,000 | $32,009,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,750,000 | $2,555,000 | 0.19% |
| Rock Springs Capital Management LP | 5,000,000 | $4,672,000 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,736,000 | 0.12% |
| DAFNA Capital Management LLC | 250,000 | $232,000 | 0.09% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 10,000,000 | $9,344,000 | 0.07% |
| SG Americas Securities, LLC | 80,800 | $7,550,000 | 0.05% |